Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Bilastine Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel palladium-catalyzed route for bilastine intermediates ensures high yield and safety. Reliable supplier for pharmaceutical manufacturing cost reduction.
Patent CN112110811B details a novel Pd-catalyzed route for bilastine intermediates, offering high purity and scalable manufacturing for global supply chains.
Novel nickel-catalyzed route for Bilastine key intermediate reduces toxicity and cost, offering a scalable supply chain solution for global pharmaceutical manufacturers.
Novel 3-step route for bilastine intermediate via Pd-catalysis. High yield, mild conditions, cost-effective manufacturing for global supply chains.
Patent CN110803985A discloses a safe, scalable synthesis of Bilastine intermediate II using vinyl sulfate, avoiding toxic ethylene oxide and expensive noble metal catalysts.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.